Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dev Amin"'
Autor:
Joseph M. Curry, Jennifer Johnson, Mehri Mollaee, Patrick Tassone, Dev Amin, Alexander Knops, Diana Whitaker-Menezes, My G. Mahoney, Andrew South, Ulrich Rodeck, Tingting Zhan, Larry Harshyne, Nancy Philp, Adam Luginbuhl, David Cognetti, Madalina Tuluc, Ubaldo Martinez-Outschoorn
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial complex I and oxidative phosphorylation has been reported to correlate with improved outcomes in head and neck squamous cell carcinoma (HNSCC) and other cancers. This
Externí odkaz:
https://doaj.org/article/c9c4b795175a4c32b103ba961cafc5b2
Autor:
Dev Amin, Chandala Chitguppi, Vivian Xu, Cameron Haghshenas, Richard Gorniak, Mindy Rabinowitz, Elina Toskala, Marc Rosen, Gurston Nyquist
Publikováno v:
Otolaryngology–Head and Neck Surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f08edc066152de90ef12a97417881007
https://doi.org/10.1002/ohn.259
https://doi.org/10.1002/ohn.259
Autor:
Patrick Tassone, Robert Stapp, Tony Richa, Dev Amin, Charalambos C. Solomides, Ubaldo E. Martinez-Outschoorn, Ulrich Rodeck, Mehri Mollaee, Tingting Zhan, David Cognetti, Jennifer Johnson, Joseph Curry, Adam Luginbuhl
Publikováno v:
The Laryngoscope. 130
OBJECTIVES Alterations of cellular metabolism have been implicated in immune dysfunction in the tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC). Metformin has recently emerged as a candidate of interest for combination w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5d5a286d29a69ce6a561eb51e0ebab8
https://doi.org/10.1002/lary.28336
https://doi.org/10.1002/lary.28336
Autor:
Dev, Amin, Tony, Richa, Mehri, Mollaee, Tingting, Zhan, Patrick, Tassone, Jennifer, Johnson, Adam, Luginbuhl, David, Cognetti, Ubaldo, Martinez-Outschoorn, Robert, Stapp, Charalambos, Solomides, Ulrich, Rodeck, Joseph, Curry
Publikováno v:
The LaryngoscopeBIBLIOGRAPHY. 130(9)
Alterations of cellular metabolism have been implicated in immune dysfunction in the tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC). Metformin has recently emerged as a candidate of interest for combination with immunot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8151ff40009d3e28402acda904e82752
https://pubmed.ncbi.nlm.nih.gov/31593308
https://pubmed.ncbi.nlm.nih.gov/31593308
Autor:
My G. Mahoney, Tingting Zhan, Andrew P. South, Ulrich Rodeck, David Cognetti, Mehri Mollaee, Larry Harshyne, Patrick Tassone, Dev Amin, Jennifer Johnson, Diana Whitaker-Menezes, Adam Luginbuhl, Ubaldo E. Martinez-Outschoorn, Madalina Tuluc, Joseph Curry, Alexander Knops, Nancy J. Philp
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 8 (2018)
Frontiers in Oncology, Vol 8 (2018)
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial complex I and oxidative phosphorylation has been reported to correlate with improved outcomes in head and neck squamous cell carcinoma (HNSCC) and other cancers. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f341ca2aa9839509b3e03f4aeb592452
https://doi.org/10.3389/fonc.2018.00436
https://doi.org/10.3389/fonc.2018.00436
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.